FOXO Technologies Inc. (NYSE American: FOXO), a company specializing in commercial physical and biological research with a current market capitalization of $9 million, announced today that its stockholders have approved a series of proposals during a Special Meeting held on Friday.
This strategic move is aimed at increasing the market price of the company's common stock, potentially improving its marketability and compliance with NYSE American listing requirements. The company's current financial position shows a concerning current ratio of 0.08, indicating significant liquidity challenges.
In addition to the reverse stock split, stockholders also approved the issuance of shares of Class A common stock in amounts exceeding 20% of the currently outstanding shares in connection with various agreements, including the Smithline Exchange Agreement, the Strata Purchase Agreement with ClearThink Capital Partners (WA:CPAP), LLC, and the Securities Purchase Agreement with an institutional investor.
Furthermore, the proposal to adjourn the Special Meeting, if necessary, to solicit additional proxies was also approved. However, as there were sufficient votes to approve the preceding proposals, no adjournment was required. All proposals were passed with a significant majority, and no votes against or abstentions were recorded for the reverse stock split and the adjournment proposal. The other proposals received a majority of votes in favor, with some abstentions.
In other recent news, FOXO Technologies Inc. has made a series of strategic decisions that aim to strengthen its financial position and operational capabilities. The company has finalized the acquisition of Rennova Community Health (NYSE:CYH), Inc., a move that aligns with its growth strategy and expands its presence in the healthcare sector.
In addition, FOXO Technologies has reached an agreement to convert outstanding senior debt into equity, a decision aimed at resolving a default on its 15% Senior Promissory Notes. This move is set to strengthen the company's financial position and ensure compliance with the listing requirements of the NYSE American.
The company has also amended its Certificate of Incorporation to authorize the issuance of up to 35,000 shares of Series A Cumulative Convertible Redeemable Preferred Stock. This action expands the company's capital structure and establishes specific rights and preferences for the new series of preferred stock.
FOXO Technologies has made changes to its bylaws affecting shareholder meeting quorum requirements. The company's Board of Directors has approved the change, which lowers the quorum needed from a majority to one-third of outstanding shares. This adjustment aims to facilitate the transaction of business during shareholder meetings.
Lastly, the company has engaged in strategic agreements and modifications to its executive compensation structure. It has signed a Corporate Development Advisory Agreement with C L Talent Inc., and engaged J.H. Darbie & Co., Inc. as a nonexclusive financial adviser.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.